We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn MoreX Don't have an account? Register
AbbVie to acquire UK-based antibody medicines company DJS Antibodies
By NS Healthcare Staff Writer21 Oct 2022
DJS Antibodies is engaged in the development and commercialisation of antibody medicines that target difficult-to-drug disease-causing proteins, and its lead programme, DJS-002 is currently being studied in Idiopathic Pulmonary Fibrosis (IPF) and other fibrotic diseases
HOOKIPA, Roche sign licensing deal for KRAS-mutated cancer....
Roche will pay an upfront amount of $25m to HOOKIPA Pharma and
Jazz Pharmaceuticals, Zymeworks sign licence deal for zanidatamab
Under the terms of the deal, Jazz will obtain exclusive rights to
Novavax gets FDA EUA for COVID-19 Vaccine, Adjuvanted....
The FDA Emergency Use Authorisation decision was based on the findings of
Deck the Halls this Winter with New Limited-Edition....
Introducing Voortman® holiday wafers and cookies, now on shelves across the U.S.
Lilly to acquire genetic medicine company Akouos for $487m19 Oct 22
LG Chem to buy oncology-focussed biopharma firm AVEO for $566m19 Oct 22
Gilead, MacroGenics collaborate on bispecific antibodies18 Oct 22
Medlab Middle East generated business worth AED469 million during the 2022 exhibition in Dubai 28 Sep 22
GSK, Microsoft partner with CHDS Nepal on disease surveillance project 22 Sep 22
bluebird bio gets FDA approval for Skysona to treat cerebral adrenoleukodystrophy 19 Sep 22
Multicultural Foodservice & Hospitality Alliance and Unilever Food Solutions’ #FairKitchens Helps “ELEVATE” Diversity, Equity and Inclusion in the Restaurant, Foodservice and Hospitality Industry19 Oct 22
The Vitamin Shoppe’s BodyTech® Sports Nutrition Brand and Warner Bros. Consumer Products Launch Exclusive Flavor Collaborations Inspired by Characters from the DC Universe including Superman, Batman, Wonder Woman, Black Adam and More19 Oct 22
Global Cannabidiol Legalization Trend to Shape the CBD Market’s Future Growth19 Oct 22
Milestone Pharmaceuticals’ etripamil nasal spray meets primary endpoint of phase 3 trial in PSVT
EMA’s CHMP recommends approval for Boehringer Ingelheim’s spesolimab
UK announces over £800m funding to improve innovation, growth and patient safety
Odyssey Therapeutics secures $168m in Series B financing round
AdAlta partners with GPCR Therapeutics for new cancer treatment
Arjo20 Sep 22
Randox Biosciences06 Feb 18
Thermo Scientific30 Sep 14
Kerry Bio-Science18 Jul 13
<?php// echo do_shortcode('[adunit_2]'); ?>
Global survey reveals food prices vastly....14 Oct 22
BioNTech enters mRNA research partnership with....07 Oct 22
Novo Nordisk teams up with Microsoft....13 Sep 22
WuXi STA opens new oligonucleotide and....07 Jul 22
AstraZeneca’s Alexion to buy LogicBio to....04 Oct 22
Myovant rejects Sumitovant Biopharma’s $2.5bn takeover....03 Oct 22
GENFIT to acquire Swiss biotech company....20 Sep 22
Matt Cutts, a software engineer and former head of the web spam team at Google, stated back in 2012 that "spammy directories" are disregarded while those who "excercise editorial discretion" worth it.
Even though countless business directories litter the internet, they won't all offer a positive change. Don't take unneeded risks and suggest your website to one that Google loves!